Biotech

All Articles

Lilly, Haya ink $1B biobuck weight problems deal to explore darker genome

.Eli Lilly's search for weight problems targets has actually led it to the black genome. The Big Pha...

ArsenalBio elevates $325M, rotates out of past lead resource

.Arsenal Biosciences is actually carrying on up. The tissue treatment provider has actually added on...

Lilly- backed effective weight loss biotech documents IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually fi...

Aelis' marijuana usage medication flunks period 2b, steering Indivior to reconsider $100M option

.Aelis Farma's chances of securing a simple, positive choice on a $100 thousand option payment have ...

ProKidney stops period 3 trial not needed to have for tissue therapy authorization

.ProKidney has ceased among a pair of phase 3 tests for its own tissue therapy for kidney health con...

Vaxcyte surges on 'magnificent' 31-valent PCV win against Pfizer

.Vaxcyte introduced what professionals called "magnificent" stage 1/2 records for its own 31-valent ...

Recursion's human brain condition test shows little evidence of effectiveness

.Recursion has actually stumbled with a very early test of its tech-enabled method to drug explorati...

Acepodia, Pfizer click all together for chemistry-based tissue therapy

.Contact it a situation of great chemical make up: Acepodia, a biotech based on Nobel Champion scien...

Praxis epilepsy drug lowers seizures in phase 2 trial

.Praxis Accuracy Medicines has scored another midphase gain in epilepsy this year, with its salt sta...

Three officers surrender as Dyne messages combined records for DMD prospect

.After getting away from a professional hold several years back, Dyne Rehab has actually shown brand...